new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Achillion Pharmaceuticals Inc patents

Recent patent applications related to Achillion Pharmaceuticals Inc. Achillion Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Achillion Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Achillion Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Achillion Pharmaceuticals Inc-related inventors




Date Achillion Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
03/09/17Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
03/02/17Compounds for the treatment of medical disorders
03/02/17Amide compounds for treatment of medical disorders
03/02/17Phosphonate compounds for treatment of medical disorders
03/02/17Ether compounds for treatment of medical disorders
01/12/17Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
12/15/16Compounds for treatment of complement mediated disorders
12/15/16Amide compounds for treatment of complement mediated disorders
12/15/16Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
12/15/16Phosphonate compounds for treatment of complement mediated disorders
12/15/16Ether compounds for treatment of complement mediated disorders
06/23/16Sovaprevir polymorphs and methods of manufacture thereof
04/28/16Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
04/28/16Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
03/24/164-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/12/15Novel process for producing sovaprevir
08/27/15Factor d inhibitors useful for treating inflammatory disorders
08/27/15Compounds for treatment of complement mediated disorders
08/27/15Alkyne compounds for treatment of complement mediated disorders
08/27/15Amide compounds for treatment of complement mediated disorders
08/27/15Amino compounds for treatment of complement mediated disorders
08/27/15Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
08/27/15Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
08/27/15Ether compounds for treatment of complement mediated disorders
08/27/15Phosphonate compounds for treatment of complement mediated disorders
10/16/14Deuterated nucleoside prodrugs useful for treating hcv
10/16/14Highly active nucleoside derivative for the treatment of hcv
09/18/14Sovaprevir tablets
09/18/14Ach-0142684 sodium salt polymorph, composition including the same, and manufacture thereof
09/18/14Sovaprevir polymorphs and methods of manufacture thereof
09/18/14Novel processes for producing sovaprevir
09/18/14Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
07/24/144-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
04/24/14New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
06/27/132-substituted-thienoquinolones and related compounds as anti-infective agents
11/29/12Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
05/10/12New isothiazoloquinolones and related compounds as anti-infective agents
05/03/12Thiazole compounds and methods of use
02/16/128-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
09/15/11Isothiazoloquinolones and related compounds as anti-infective agents
09/01/11Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
06/23/11Elvucitabine pharmaceutical compositions
03/24/11Macrocyclic peptides as inhibitors of viral replication
11/18/10Tertiary amine substituted peptides useful as inhibitors of hcv replication
10/07/10Low dose therapy for treating viral infections
10/07/10Hydroxythienoquinolones and related compounds as anti-infective agents
08/26/104-amino-4-oxobutanoyl peptides as inhibitors of viral replication
06/17/104-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
05/20/10Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
04/15/10Cells expressing chimeric proteins and assays using such cells
02/04/10Combination therapy for treating hepatitis c infections
12/10/09Substituted aminothiazole prodrugs of compounds with anti-hcv activity
03/26/09Urea-containing peptides as inhibitors of viral replication







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Achillion Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Achillion Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';